Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Hepatocellular Carcinoma
100%
Cholangiocarcinoma
51%
Liver Transplantation
46%
Diseases
37%
Surgery
33%
Overall Survival
33%
Yttrium 90
29%
Hepatic Portal Vein
29%
Hepatectomy
29%
Radioembolization
28%
Recurrent Disease
27%
Embolization
23%
Nonalcoholic Fatty Liver
20%
Microsphere
20%
Heart Arrest
18%
Cholecystectomy
18%
Systematic Review
18%
Colorectal Liver Metastasis
18%
Tumor
17%
Liver Graft
16%
Graft Failure
16%
Gallbladder Cancer
13%
Disease Free Survival
13%
Decision Making
11%
Liver Tumor
11%
Response Evaluation Criteria in Solid Tumors
11%
Liver Disease
11%
Chemotherapy
11%
Neoplasm
11%
Liver Cancer
10%
Metastatic Carcinoma
10%
Neoadjuvant Therapy
10%
Liver Surgery
10%
Postoperative Complication
10%
Liver Failure
9%
Clostridium Difficile Infection
9%
Aortoiliac Disease
9%
General Surgery
9%
Stereotactic Body Radiation Therapy
9%
Hypothermia
9%
Efferocytosis
9%
Hyperbilirubinemia
9%
Arm
9%
Steatohepatitis
9%
Intracardiac Thrombosis
9%
Bile Duct Injury
9%
Communication Barrier
9%
Bleeding
9%
Caroli Disease
9%
Cannulation
9%
Keyphrases
Hepatocellular Carcinoma
96%
Liver Transplantation
45%
Surgical Resection
27%
Resection
26%
Surgical Management
23%
Tumor
22%
Intrahepatic Cholangiocarcinoma (iCCA)
22%
Overall Survival
20%
Portal Vein Embolization
20%
Liver
19%
Radioembolization
19%
Yttrium-90
18%
Single-center Experience
18%
Phase II Trial
18%
Colorectal Cancer Liver Metastasis (CRCLM)
18%
Graft Failure
17%
Nonalcoholic Steatohepatitis
16%
Gallbladder Cancer
13%
Disease-free Survival
13%
Initially Unresectable
13%
Cirrhosis
12%
Hepatitis B Virus
12%
Neoadjuvant
12%
Liver Tumor
11%
Perihilar Cholangiocarcinoma
11%
Liver Transplant Recipients
11%
Clinical Significance
11%
Liver Resection
11%
Complete Response
11%
Reperfusion
10%
Positive Margins
10%
Neoadjuvant Therapy
10%
Surgical Treatment
10%
Clinical Outcomes
10%
Unresectable Hepatocellular Carcinoma (uHCC)
10%
Liver Failure
9%
Liver Cancer
9%
95% Confidence Interval
9%
Benchmark Values
9%
Human Liver
9%
Expert Center
9%
Imaging Response
9%
Fibrosis Progression
9%
Stereotactic Body Radiation Therapy
9%
Multicentric
9%
Prolonged Cardiac Arrest
9%
Postoperative Regret
9%
Transcriptome Analysis
9%
Clonal Evolution
9%
Outcome Prediction
9%